Sotalol tablet how supplied storage and handling

Revision as of 06:03, 10 February 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search
Sotalol
BETAPACE® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
SOTALOL HYDROCHLORIDE®
FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Sotalol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

Betapace (sotalol hydrochloride); capsule-shaped light-blue scored tablets imprinted with the strength and “Betapace”, are available as follows:

NDC 50419-105-10

80 mg strength, bottle of 100

NDC 50419-109-10

120 mg strength, bottle of 100

NDC 50419-106-10

160 mg strength, bottle of 100

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [See USP Controlled Room Temperature].

©2011, Bayer HealthCare Pharmaceuticals Inc. All rights reserved.

Manufactured for: Bayer HealthCare Pharmaceuticals Inc. Wayne, NJ 07470

Manufactured in Finland[1]

References

  1. "BETAPACE (SOTALOL HYDROCHLORIDE) TABLET [BAYER HEALTHCARE PHARMACEUTICALS INC.]".

Adapted from the FDA Package Insert.